Technical and Clinical Overview: Spinal Cord Stimulation

Area of Science:

• Neuromodulation
• Neurosurgery
• Pain Management

Background:

• Spinal cord stimulation (SCS) has evolved from basic systems to sophisticated technologies.
• Advancements focus on improving therapy delivery, patient tolerance, device longevity, and expanding treatment indications.

Purpose of the Study:

• To evaluate the current state of spinal cord stimulation implants and devices.
• To review the scientific evidence, waveforms, publications, and support data for SCS manufacturers.

Main Methods:

• Evaluation of SCS technologies from Food and Drug Administration-approved companies.
• Review of manufacturer-provided scientific evidence, waveforms, publications, and support data.

Main Results:

• The study reviewed SCS devices from Medtronic, Abbott, Boston Scientific, Saluda, Biotronik, and Nevro.
• Analysis included each company's scientific evidence, waveforms, and publications.

Conclusions:

• Spinal neuromodulation technology is rapidly advancing.
• Level 1 clinical evidence demonstrates SCS superiority over medical management for various painful conditions.